About 1 result found for searched term "Glenzocimab" (0.12 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24922 | Glenzocimab | Others |
| ACT017 | ||
| Glenzocimab (ACT017) is a Fab fragment of humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential for the research of acute ischemic stroke. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
